Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancer
- 28 February 2006
- journal article
- clinical trial
- Published by Elsevier in The Breast
- Vol. 15 (1) , 64-68
- https://doi.org/10.1016/j.breast.2005.04.009
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Insulin-like growth factors and neoplasiaNature Reviews Cancer, 2004
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasiaBritish Journal of Cancer, 1997
- Insulin-like growth factor binding proteins and their role in controlling IGF actionsCytokine & Growth Factor Reviews, 1997
- Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex.Endocrinology, 1994
- Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patientsThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Insulin-Like Growth Factor (IGF)-Binding Protein-3 Blocks IGF-I-Induced Receptor Down-Regulation and Cell Desensitization in Cultured Bovine Fibroblasts*Endocrinology, 1991
- Effect of Tamoxifen on Serum Insulinlike Growth Factor I Levels in Stage I Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1990
- Binding proteins for the insulin-like growth factors: Structure, regulation and functionProgress in Growth Factor Research, 1989
- Cloning and Expression of the Growth Hormone-Dependent Insulin-Like Growth Factor-Binding ProteinMolecular Endocrinology, 1988